Welcome to our dedicated page for Lftd Partners SEC filings (Ticker: LIFD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings and related regulatory disclosures for LFTD Partners Inc. (OTCQB: LIFD), the Jacksonville, Florida-based parent of Lifted Made. While recent company information is often shared through press releases, LFTD Partners directs investors to its SEC filings for full descriptions of its business and detailed risk factors.
Through its filings, LFTD Partners reports on the operations of Lifted Made, which manufactures and sells Urb hemp-derived and other psychoactive products, Mielos hemp-free health and wellness gummies, and Rebel hemp-free energy gummies. The filings also describe exclusive manufacturing arrangements for Diamond Supply Co. and Cali Sweets hemp-derived products, and manufacturing of hemp-derived products in the United States for a subsidiary of a large, publicly traded U.S. marijuana company. In addition, the company discloses its 4.99% equity stakes in hemp-derived beverage maker Ablis and craft distillers Bendistillery Inc. d/b/a Crater Lake Spirits and Bend Spirits, Inc.
Regulatory and legislative risk is a key focus in LFTD Partners' formal disclosures. The company has publicly discussed federal legislation that would ban intoxicating hemp-derived consumable products as of a specified future date, noting that such a ban could significantly reduce Lifted Made's sales, require goodwill and investment impairment charges, and force inventory write-offs. SEC filings are the primary venue where these and other risk factors, contingencies, and accounting impacts are described in detail.
On this page, users can review LFTD Partners' annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K when available, along with any proxy statements and beneficial ownership or insider transaction reports such as Form 4. Real-time updates from the EDGAR system are combined with AI-powered summaries that help explain complex sections, highlight key changes from prior periods, and point out items such as segment performance, goodwill and investment accounting, and disclosures related to hemp and cannabis legislation.
By using this filings page, investors and researchers can move from headline financial results in press releases to the underlying SEC documents that govern how LFTD Partners presents its financial condition, operations, and risk profile in the context of hemp-derived products, wellness and energy gummies, and its exposure to evolving cannabis markets.
LFTD Partners (LIFD) reported a profitable Q3 2025, with net sales of $9,056,742 and net income of $634,257, reversing a loss a year ago. Gross profit rose to $4,157,495 on lower operating expenses, lifting income from operations to $1,312,791.
For the nine months, net sales were $28,505,928 and net income was $62,265. Cash and cash equivalents were $1,920,664, with restricted cash of $1,000,000. The company reduced Surety Bank borrowings during Q3, including a $592,050 paydown on its working capital loan. Shares outstanding were 14,822,678 as of November 13, 2025.
Risks increased materially. On November 12, 2025, a federal act was signed that bans intoxicating hemp-derived consumable products nationally on November 12, 2026. Hemp-derived products accounted for approximately 47% of Q3 sales. Management warns the act could trigger goodwill impairments on total goodwill of $23,092,794, potential impairment of a $399,200 investment, and significant inventory write-offs. The company states there is substantial doubt about its ability to continue as a going concern.
FAQ
What is the current stock price of Lftd Partners (LIFD)?
What is the market cap of Lftd Partners (LIFD)?
